BCC
LMAT icon

Bridge City Capital’s LeMaitre Vascular LMAT Stock Holding History

Bridge City Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.68M Buy
70,390
+3,767
+6% +$359K 2.13% 8
2025
Q4 		$5.4M Sell
66,623
-7,235
-10% -$623K 1.59% 23
2025
Q3 		$6.46M Buy
73,858
+309
+0.4% +$27.6K 1.73% 15
2025
Q2 		$6.11M Sell
73,549
-824
-1% -$68.9K 1.71% 14
2025
Q1 		$6.24M Sell
74,373
-20,098
-21% -$1.87M 1.87% 10
2024
Q4 		$8.7M Buy
94,471
+6,430
+7% +$618K 2.32% 5
2024
Q3 		$8.18M Sell
88,041
-2,165
-2% -$188K 2.25% 3
2024
Q2 		$7.42M Buy
90,206
+17,002
+23% +$1.25M 2.49% 5
2024
Q1 		$4.86M Buy
73,204
+1,890
+3% +$117K 1.77% 7
2023
Q4 		$4.05M Buy
71,314
+12,453
+21% +$652K 1.57% 12
2023
Q3 		$3.21M Buy
58,861
+1,750
+3% +$104K 1.62% 11
2023
Q2 		$3.84M Sell
57,111
-15,960
-22% -$974K 1.82% 7
2023
Q1 		$3.76M Sell
73,071
-264
-0.4% -$12.8K 1.89% 7
2022
Q4 		$3.38M Sell
73,335
-513
-0.7% -$24K 1.73% 11
2022
Q3 		$3.74M Buy
73,848
+2,489
+3% +$124K 2.05% 7
2022
Q2 		$3.25M Sell
71,359
-128
-0.2% -$5.73K 1.72% 12
2022
Q1 		$3.32M Sell
71,487
-362
-0.5% -$16.2K 1.55% 15
2021
Q4 		$3.61M Buy
71,849
+640
+0.9% +$33.1K 1.49% 15
2021
Q3 		$3.78M Sell
71,209
-18,923
-21% -$1.07M 1.71% 11
2021
Q2 		$5.5M Sell
90,132
-3,003
-3% -$160K 1.88% 7
2021
Q1 		$4.54M Sell
93,135
-938
-1% -$44K 1.51% 11
2020
Q4 		$3.81M Sell
94,073
-977
-1% -$34.9K 1.45% 21
2020
Q3 		$3.09M Sell
95,050
-9,152
-9% -$275K 1.48% 21
2020
Q2 		$2.75M Buy
104,202
+3,272
+3% +$85.5K 1.26% 32
2020
Q1 		$2.52M Buy
100,930
+31,834
+46% +$983K 1.22% 36
2019
Q4 		$2.48M Buy
69,096
+13,237
+24% +$457K 1.02% 43
2019
Q3 		$1.91M Buy
55,859
+12,065
+28% +$385K 0.82% 61
2019
Q2 		$1.23M Buy
43,794
+193
+0.4% +$5.36K 0.67% 76
2019
Q1 		$1.35M Buy
+43,601
New +$1.16M 0.79% 66

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bridge City Capital's LMAT Position: Q1 2026 in Review

Bridge City Capital increased its LeMaitre Vascular (LMAT) stake by 5.7% in Q1 2026, buying an estimated $359K and bringing the position to 70,390 shares worth $7.68M. The position accounts for 2.13% of the portfolio, ranked #8.

Bridge City Capital first reported a position in LMAT in Q1 2019 and has held it in 29 quarters since. The position peaked at $8.7M in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Bridge City Capital held 70,390 shares of LeMaitre Vascular worth $7.68M as of Q1 2026.
  • Bridge City Capital bought 3,767 LeMaitre Vascular shares in Q1 2026, an estimated $359K.
  • LeMaitre Vascular made up 2.13% of Bridge City Capital's portfolio in Q1 2026, its #8 holding.
  • Bridge City Capital first reported a position in LeMaitre Vascular in Q1 2019 and has held it in 29 quarters since.
  • Bridge City Capital's LeMaitre Vascular position peaked at $8.7M in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.